Current aspects of the spectrum of acute heart failure syndromes in a real‐life setting: the OFICA study

…, P de Groote, G Jondeau, M Galinier… - European journal of …, 2013 - Wiley Online Library
Aims To improve knowledge of epidemiological data, management, and clinical outcome of
acute heart failure (AHF) in a real‐life setting in France. Methods and results We conducted …

Iron deficiency: an emerging therapeutic target in heart failure

…, A Mebazaa, P de Groote, T Damy, M Galinier - Heart, 2014 - heart.bmj.com
In patients with heart failure, iron deficiency is frequent but overlooked, with a prevalence of
30%–50%. Since it contributes to cardiac and peripheral muscle dysfunction, iron deficiency …

Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study

…, E Donal, JF Aupetit, MC Aumont, M Galinier… - Journal of the American …, 2007 - jacc.org
Objectives : The aim of this multicenter study was to evaluate the prognostic impact of a
therapeutic strategy using plasma brain natriuretic peptide (BNP) levels. Background : The …

Sleep apnea syndromes and cardiovascular disease

JP Bounhoure, M Galinier, A Didier… - Bulletin de l'Academie …, 2005 - europepmc.org
Sleep-disordered breathing is very common and is associated with an increased risk of
cardiovascular disease, cardiac arrhythmia and stroke. There are two types of sleep apnea: …

Depressed low frequency power of heart rate variability as an independent predictor of sudden death in chronic heart failure

M Galinier, A Pathak, J Fourcade… - European heart …, 2000 - academic.oup.com
Aims Identification of patients with chronic heart failure at risk for sudden death remains
difficult. We sought to assess the prognostic value for all-cause and sudden death of time and …

Initiation of sacubitril/valsartan in haemodynamically stabilised heart failure patients in hospital or early after discharge: primary results of the randomised …

…, MF Seronde, M Galinier, M Noutsias… - European journal of …, 2019 - Wiley Online Library
Aims To assess tolerability and optimal time point for initiation of sacubitril/valsartan in
patients stabilised after acute heart failure (AHF). Methods and results TRANSITION was a …

Acute heart failure congestion and perfusion status–impact of the clinical classification on in‐hospital and long‐term outcomes; insights from the ESC‐EORP‐HFA …

…, M Galinier, P Tourikis, M Stavroula… - European journal of …, 2019 - Wiley Online Library
Aims Classification of acute heart failure (AHF) patients into four clinical profiles defined by
evidence of congestion and perfusion is advocated by the 2016 European Society of …

B-CONVINCED: Beta-blocker CONtinuation Vs. INterruption in patients with Congestive heart failure hospitalizED for a decompensation episode

…, P Jourdain, E Fauveau, M Galinier… - European heart …, 2009 - academic.oup.com
Aims Whether or not beta-blocker therapy should be stopped during acutely decompensated
heart failure (ADHF) is unsure. Methods and results In a randomized, controlled, open …

Early eplerenone treatment in patients with acute ST-elevation myocardial infarction without heart failure: the Randomized Double-Blind Reminder Study

…, P Coste, Y Cottin, D Ducos, M Galinier… - European heart …, 2014 - academic.oup.com
Aims We aimed to assess the impact of eplerenone on cardiovascular (CV) outcomes in
STEMI without known heart failure, when initiated within 24 h of symptom onset. Methods and …

Is the gap between guidelines and clinical practice in heart failure treatment being filled? Insights from the IMPACT RECO survey

…, P Clerson, A Ducardonnet, M Galinier… - European journal of …, 2007 - Wiley Online Library
Background Recent registries have shown that recommended drugs for the treatment of
chronic heart failure (CHF) are under‐prescribed in daily practice. Aims To determine …